Articles from Stateline Distributors

VICAPSYN™, the Company's immune-isolation technology for islet cell transplantation in type 1 diabetes, remains an active asset of Vicapsys and is being carried forward under the Company's new operating structureStrategy integrates the program with the Company's tribal and federal health channel, including the Indian Health Service network, from clinical development through deliveryPreclinical proof-of-concept work advancing toward a Phase 1 human clinical trialCompany exploring partnerships in Argentina that could establish an international arm and a Latin American licensing opportunity alongside its U.S. programVertex Pharmaceuticals' $950 million acquisition of Semma Therapeutics, and clinical results that still require chronic immunosuppression, underscore both the value of islet cell therapy and the problem VICAPSYN™ is designed to solve

FutureBrand Hispanic America onboards Vicapsys and delivers a unified visual identity for Vicapsys Life Sciences and its Stateline subsidiaryTwo linked brands under one visual system: Vicapsys as the umbrella brand and Stateline as the operating brand, now being applied across corporate materials, investor communications, Stateline's commercial documents and packaging, and the Company's public disclosuresThe identity rollout is the first of the Company's post-merger housekeeping steps; its OTCID application, Rule 15c2-11 quotation process and PCAOB audit are underway alongside it

Advisors bring experience across federal government, tribal governance and economic development, pharmaceutical development and manufacturing, oncology in Puerto Rico, international financial operations, brand strategy and hospital group purchasingAdvisory Board supports management on the Company's federal and tribal channel strategy, the NitroMist® relaunch and the planned Puerto Rico manufacturing facility

Stateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party logistics partner DrugzoneStrategic tribal 8(a) teaming agreement gives the combined company access to set-aside and sole-source federal contracting channels, including Indian Health Service pharmaceutical supplyVICP has signed a definitive agreement to acquire NitroMist® (nitroglycerin) lingual aerosol, NDA 021780, for a US$2.0million convertible note and is preparing stability, medium-fill and pre-production batches with its contract manufacturing partner for the product's relaunchCompany in discussions to acquire an approximately 120,000-square-foot former big-pharma API manufacturing facility in Puerto Rico, including 50,000 square feet of cleanroom manufacturing space and 70,000 square feet of distribution space

Stateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party logistics partner DrugzoneStrategic tribal 8(a) teaming agreement gives the combined company access to set-aside and sole-source federal contracting channels, including Indian Health Service pharmaceutical supplyVICP has signed a definitive agreement to acquire NitroMist® (nitroglycerin) lingual aerosol, NDA 021780, for a US$2.0million convertible note and is preparing stability, medium-fill and pre-production batches with its contract manufacturing partner for the product's relaunchCompany in discussions to acquire an approximately 120,000-square-foot former big-pharma API manufacturing facility in Puerto Rico, including 50,000 square feet of cleanroom manufacturing space and 70,000 square feet of distribution space